Biodistribution of a Radiolabeled Antibody in Mice as an Approach to Evaluating Antibody Pharmacokinetics
- PMID: 30563123
- PMCID: PMC6320949
- DOI: 10.3390/pharmaceutics10040262
Biodistribution of a Radiolabeled Antibody in Mice as an Approach to Evaluating Antibody Pharmacokinetics
Abstract
(1) Background: Monoclonal antibodies are used in the treatment of multiple conditions including cancer, autoimmune disorders, and infectious diseases. One of the initial steps in the selection of an antibody candidate for further pre-clinical development is determining its pharmacokinetics in small animal models. The use of mass spectrometry and other techniques to determine the fate of these antibodies is laborious and expensive. Here we describe a straightforward and highly reproducible methodology for utilizing radiolabeled antibodies for pharmacokinetics studies. (2) Methods: Commercially available bifunctional linker CHXA" and 111Indium radionuclide were used. A melanin-specific chimeric antibody A1 and an isotype matching irrelevant control A2 were conjugated with the CHXA", and then radiolabeled with 111In. The biodistribution was performed at 4 and 24 h time points in melanoma tumor-bearing and healthy C57BL/6 female mice. (3) The biodistribution of the melanin-binding antibody showed the significant uptake in the tumor, which increased with time, and very low uptake in healthy melanin-containing tissues such as the retina of the eye and melanized skin. This biodistribution pattern in healthy tissues was very close to that of the isotype matching control antibody. (4) Conclusions: The biodistribution experiment allows us to assess the pharmacokinetics of both antibodies side by side and to make a conclusion regarding the suitability of specific antibodies for further development.
Keywords: antibodies; biodistribution; mouse models; pharmacokinetics; radiolabeling.
Conflict of interest statement
The authors declare no conflict of interest. E. Dadachova is a co-inventor on the patent describing radioimmunotherapy of melanoma.
Figures
Similar articles
-
Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenografts.Cancer Res. 2001 Jun 1;61(11):4474-82. Cancer Res. 2001. PMID: 11389078
-
Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients.J Nucl Med. 1998 Dec;39(12):2097-104. J Nucl Med. 1998. PMID: 9867150 Clinical Trial.
-
Pharmacokinetics, biodistribution, and dosimetry of specific and control radiolabeled monoclonal antibodies in patients with primary head and neck squamous cell carcinoma.Cancer Res. 1995 Mar 1;55(5):1060-9. Cancer Res. 1995. PMID: 7866989 Clinical Trial.
-
Targeting primary human Ph(+) B-cell precursor leukemia-engrafted SCID mice using radiolabeled anti-CD19 monoclonal antibodies.J Nucl Med. 2003 Jul;44(7):1105-12. J Nucl Med. 2003. PMID: 12843229
-
Experimental approaches to increase radiolabeled antibody localization in tumors.Cancer Res. 1995 Dec 1;55(23 Suppl):5729s-5732s. Cancer Res. 1995. PMID: 7493336 Review.
Cited by
-
Evaluating the Targeting of a Staphylococcus-aureus-Infected Implant with a Radiolabeled Antibody In Vivo.Int J Mol Sci. 2023 Feb 22;24(5):4374. doi: 10.3390/ijms24054374. Int J Mol Sci. 2023. PMID: 36901805 Free PMC article.
-
Human monoclonal antibodies against Staphylococcus aureus surface antigens recognize in vitro and in vivo biofilm.Elife. 2022 Jan 6;11:e67301. doi: 10.7554/eLife.67301. Elife. 2022. PMID: 34989676 Free PMC article.
-
Safety Evaluation of an Alpha-Emitter Bismuth-213 Labeled Antibody to (1→3)-β-Glucan in Healthy Dogs as a Prelude for a Trial in Companion Dogs with Invasive Fungal Infections.Molecules. 2020 Aug 8;25(16):3604. doi: 10.3390/molecules25163604. Molecules. 2020. PMID: 32784359 Free PMC article.
-
Targeted Fluorogenic Cyanine Carbamates Enable In Vivo Analysis of Antibody-Drug Conjugate Linker Chemistry.J Am Chem Soc. 2021 Dec 29;143(51):21667-21675. doi: 10.1021/jacs.1c10482. Epub 2021 Dec 20. J Am Chem Soc. 2021. PMID: 34928588 Free PMC article.
-
Drug Delivery Technology Development in Canada.Pharmaceutics. 2019 Oct 17;11(10):541. doi: 10.3390/pharmaceutics11100541. Pharmaceutics. 2019. PMID: 31627471 Free PMC article.
References
Grants and funding
LinkOut - more resources
Full Text Sources
